로딩 중…
지수 로딩 중…
Damora Therapeutics Inc. Common Stock
DMRA· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$21.23-0.89%
2026-06-18
Price Chart
Damora Therapeutics Inc. Common Stock+537.54%
Financials
No data
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $1.31B |
| Revenue | $0.00 |
| Net Income | $-235M |
| Total Assets | $535M |
| Net Assets | $510M |
| Value | |
| P/B | 2.56x |
| Profitability | |
| ROE | -46.07% |
| ROA | -43.91% |
| Financial Health | |
| Debt Ratio | 4.93% |
| Total Debt | $1M |
| Cash | $533M |
| Current Ratio | 22.48x |
| Performance | |
| 1Y Return | 537.54% |
| 1M Return | -11.69% |
| From 52W High | -44.61% |
| 1Y MDD | -72.38% |
| Trading | |
| Volume | 1,166,963 shares |
| Trading Value | $25M |